Orgenesis Q3 EPS $(1.93) Down From $(0.12) YoY, Sales $347.00K Up From $110.00K YoY

BenzingaNov 13, 2024 21:24

Orgenesis 3Q Rev $347,000 Vs. $110,000 >ORGS

Dow JonesNov 13, 2024 21:04

Orgenesis | 10-Q: Q3 2024 Earnings Report

SECNov 13, 2024 21:02 · Announcements

Express News | Orgenesis Provides Third Quarter 2024 Business Update

BreakingsNov 13, 2024 21:00

Press Release: Orgenesis Provides Third Quarter 2024 Business Update

Dow JonesNov 13, 2024 21:00

Orgenesis Commences Trading on OTCQX Best Market

GlobeNewswireOct 21, 2024 20:00

Bright Minds DRUG Private Placement; Orgenesis ORGS NASDAQ Delisting

BioPharmCatalystOct 19, 2024 02:51

Sector Update: Health Care Stocks Steady Pre-Bell Friday

MT NewswiresOct 18, 2024 21:12

Orgenesis Shares Fall Pre-Bell Amid Nasdaq Panel Deciding to Delist Shares

MT NewswiresOct 18, 2024 20:14

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaOct 18, 2024 20:09

Top Premarket Decliners

MT NewswiresOct 18, 2024 20:02

Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

BenzingaOct 18, 2024 18:52

Express News | Orgenesis: Nasdaq to Delist Co 's Common Stock, Securities Trading Will Be Suspended on Oct 21

BreakingsOct 18, 2024 05:11

Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

BenzingaSep 25, 2024 07:50

Orgenesis To Carry Out 1-for-10 Reverse Stock Split On September 25th, 2024

September 23rd (Eastern Time) - $Orgenesis(ORGS.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from September 25th, 2024.

Futu NewsSep 24, 2024 07:35

Why Orgenesis (ORGS) Stock Is Down 23% Today

BenzingaSep 24, 2024 02:08

Orgenesis: Shares To Trade on Split-Adjusted Basis Beginning Sept. 25 >ORGS

Dow JonesSep 23, 2024 19:03

Express News | Orgenesis Announces Reverse Stock Split

BreakingsSep 23, 2024 19:00

Orgenesis Releases Investor Presentation and Regulatory Update

TipRanksAug 30, 2024 02:59

Express News | Orgenesis Inc: Data Indicate a Potentially Favorable Safety Profile With a Lower Incidence of Cytokine Release Syndrome

BreakingsAug 29, 2024 20:31